Literature DB >> 8850215

Regulation of lipid metabolism by cytokines during host defense.

C Grunfeld1, K R Feingold.   

Abstract

Lipid metabolism is extensively regulated during the host response to infection. As with other aspects of the host response, these events are mediated by cytokines, including tumor necrosis factor, interleukin 1 (IL-1), IL-6, and the interferons. Cytokines can decrease lipoprotein lipase and increase lipolysis in cultured fat cells. In vivo, many cytokines increase serum triglycerides by increasing very-low-density lipoprotein production. Interferons increase triglycerides predominantly by decreasing lipoprotein lipase activity and triglyceride clearance. These changes in lipid metabolism do not cause cachexia. Rather, they represent part of the host defense, as lipoproteins scavenge infectious particles such as endotoxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8850215     DOI: 10.1016/0899-9007(96)90013-1

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  22 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Authors:  Mihai G Netea; Charles A Dinarello
Journal:  J Clin Endocrinol Metab       Date:  2011-05       Impact factor: 5.958

3.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

4.  Association between C-reactive protein and type 2 diabetes in a Tunisian population.

Authors:  Hanen Belfki; Samir Ben Ali; Souha Bougatef; Decy Ben Ahmed; Najet Haddad; Awatef Jmal; Monia Abdennebi; Habiba Ben Romdhane
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

5.  High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study.

Authors:  Giovanni Zuliani; Stefano Volpato; Alessando Blè; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Giuseppe Paolisso; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2006-06-19       Impact factor: 5.162

Review 6.  Neuropeptides in the pathophysiology and treatment of cachexia.

Authors:  Stephanie M Krasnow; Daniel L Marks
Journal:  Curr Opin Support Palliat Care       Date:  2010-12       Impact factor: 2.302

Review 7.  Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.

Authors:  I W Fong
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

8.  Distribution and kinetics of lipoprotein-bound lipoteichoic acid.

Authors:  Johannes H M Levels; Philip R Abraham; Erik P van Barreveld; Joost C M Meijers; Sander J H van Deventer
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  A Study to Evaluate Lipid Profile in Treatment Naïve HIV Positive Patients.

Authors:  Anitha Devanath; Somdattaa Ray; Ravi Kumar; B S Prarthana
Journal:  Indian J Clin Biochem       Date:  2013-01-20

Review 10.  Inflammation during obesity is not all bad: evidence from animal and human studies.

Authors:  Jianping Ye; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-26       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.